-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – TBI-304H in Chemotherapy Induced Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TBI-304H in Chemotherapy Induced Anemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TBI-304H in Chemotherapy Induced Anemia Drug Details: TBI-304H is under development...
-
Product Insights
NewLikelihood of Approval Analysis for Upper Limb Muscle Spasticity
Overview How likely is it that the drugs in Upper Limb Muscle Spasticity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Upper Limb Muscle Spasticity Overview Spasms or spasticity is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CTEcells in Chronic Traumatic Encephalopathy (CTE)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CTEcells in Chronic Traumatic Encephalopathy (CTE) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CTEcells in Chronic Traumatic Encephalopathy (CTE) Drug Details: The therapeutic...
-
Sector Analysis
ICP Monitoring Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
ICP Monitoring Devices Market Report Overview The ICP monitoring devices market was valued at $163.7 million in 2023. The market will grow at a CAGR of more than 2% from 2023 to 2033. In most countries, traumatic brain injury (TBI) is the primary cause of ICP monitoring device usage. Measurement of ICP helps in the detection of brain damage and initiation of therapeutic intervention. ICP monitoring using External Ventricular Drainage (EVD) is considered the gold standard as the technique allows...
-
Product Insights
Tamakoshi Phase III
Tamakoshi Phase III is a Hydro project located in Janakpur, Nepal. The project is owned and being developed by Shanghai Investigation and Design Institute; TBI Holdings Pvt Ltd; Yunnan Provincial Energy Investment Group Co Ltd. The project is at the permitting stage. Empower your strategies with our Tamakoshi Phase III report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NB-4746 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NB-4746 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NB-4746 in Amyotrophic Lateral Sclerosis Drug Details: Small molecules are under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AST-004 in Traumatic Brain Injury
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AST-004 in Traumatic Brain Injury report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AST-004 in Traumatic Brain Injury Drug Details: AST-004 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AST-004 in Acute Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AST-004 in Acute Ischemic Stroke report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AST-004 in Acute Ischemic Stroke Drug Details: AST-004 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NTS-1104 in Acute Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NTS-1104 in Acute Ischemic Stroke report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NTS-1104 in Acute Ischemic Stroke Drug Details: NTS-1104 is under...